Suchergebnisse - "Fehn, Karen"

PubPharm (5)

1

High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination

enthalten in: Leukemia & lymphoma | 2022

von Shapiro, L. | Thakkar, A. | Gali, R. | +17

2

Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC

enthalten in: JCI insight | 2021

von Yoon, H. | Bartash, R. | Gendlina, I. | +52

UpdateOf: medRxiv. 2020 Dec 04;:. - PMID 33300012

3

Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer

enthalten in: Clinical breast cancer | 2018

von Anampa, J. | Chen, A. | Wright, J. | +5

4

A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

enthalten in: Breast cancer research and treatment | 2014

von Tu, Y. | Hershman, D. | Bhalla, K. | +13

5

Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinoma

enthalten in: Breast cancer research and treatment | 2013

von Andreopoulou, E. | Vigoda, I. | Valero, V. | +11

1
[1]